Please login to the form below

Not currently logged in
Email:
Password:

Senior AstraZeneca exec jumps ship to small biotech

Briggs Morrison unexpectedly leaves the UK firm

AstraZeneca's chief medical officer Briggs Morrison is leaving the company, according to a statement from the Anglo-Swedish company.

He will leave the world's eight largest pharma firm to join a much smaller, privately owned biotech company, whose identity has not yet been publicly revealed.

AstraZeneca's chief executive, Pascal Soriot, will take over the job of late-stage drug development on an interim basis, according to news reports. 

Meanwhile Elisabeth Björk, an associate professor of medicine at Uppsala university and leads cardiovascular and metabolic drug development at AZ, now becomes acting chief medical officer.

Morrison's departure has surprised analysts as he joined AstraZeneca just three years ago and became a key member of the Soirot's new executive team. 

Colin White, an analyst at Datamonitor Healthcare, said: “It is surprising because he was brought in by Soriot and has been a key part of Soriot's leadership team.”

12 months ago the firm successfully rejected an $118bn takeover attempt from the US pharma giant Pfizer, saying it wanted to take an independent path. 

12th June 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics